Science Explorer Interactive view Map
Company · Pleasanton · ??

Astex Pharmaceuticals

astx.comROR OpenAlex
Research works
57
▲ 11% vs 2013–17
Citations
1.1k
19.2 per fractional work
Top-10% rate
1.3%
record average 16.5%
Open access
35%
world 28%

Not ranked overall: Astex Pharmaceuticals is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 8.59× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 4.38× its world share, 1 worksImmunology and Micro…Neuroscience: 0.45× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.59× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.70× its world share, 0 worksChemistryComputer Science: 0.52× its world share, 1 worksComputer ScienceEngineering: 0.44× its world share, 1 worksEngineeringMaterials Science: 0.21× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.33× its world share, 0 worksPhysics and AstronomyMedicine: 1.74× its world share, 5 worksMedicineEconomics, Econometrics and Finance: 0.02× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.6×. Every wedge is a field page.

Who are the top researchers at Astex Pharmaceuticals?

Ranked on the composite score, Harold Keer lead among researchers whose main affiliation is Astex Pharmaceuticals.

  1. 1 Harold Keer ?? · #953,191 worldwide 46 citations · 35 works
All ranked researchers at Astex Pharmaceuticals

Which keywords describe research at Astex Pharmaceuticals?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Prognostic Factors, DNA Methylation, Histone Modification, Cancer, Epigenetic Regulation, Hematopoietic Stem Cells and Gene Expression.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Therapy10▲ 28×10 topics
  2. Prognostic Factors6▲ 24×9 topics
  3. DNA Methylation6▲ 91×1 topic
  4. Histone Modification6▲ 162×1 topic
  5. Cancer5▲ 6.3×13 topics
  6. Epigenetic Regulation4▲ 35×4 topics
  7. Hematopoietic Stem Cells4▲ 73×3 topics
  8. Gene Expression4▲ 12×4 topics
  9. AML4▲ 151×1 topic
  10. Acute Myeloid Leukemia4▲ 151×1 topic
  11. Cell Proliferation4▲ 73×4 topics
  12. Proteasome Inhibitors3▲ 81×2 topics
  13. Cancer Progression3▲ 24×3 topics
  14. Chemotherapy3▲ 7.4×11 topics
  15. HDAC Inhibitors3▲ 279×1 topic
  16. Histone Deacetylases3▲ 279×1 topic
  17. Tumor Microenvironment3▲ 15×6 topics
  18. Signal Transduction3▲ 19×4 topics
  19. Proteasome3▲ 114×1 topic
  20. Ubiquitin3▲ 114×1 topic
  21. Immunotherapy2▲ 6.9×8 topics
  22. Medicinal Chemistry2▲ 12×5 topics
  23. Oncogenic Mutations2▲ 95×2 topics
  24. Transcriptional Regulation2▲ 17×4 topics
  25. Immune Response2▲ 6.6×2 topics
  26. Immunity2▲ 12×3 topics
  27. Metastasis2▲ 12×4 topics
  28. BRAF gene2▲ 211×1 topic
  29. Lymphoma2▲ 25×3 topics
  30. MAP Kinase2▲ 211×1 topic
  31. Gene Expression Regulation2▲ 32×3 topics
  32. Minimal Residual Disease2▲ 45×2 topics
  33. Angiogenesis2▲ 7.0×2 topics
  34. Cancer Immunotherapy2▲ 21×3 topics
  35. Hematological Malignancies2▲ 76×2 topics
  36. Antiretroviral Therapy2▲ 11×3 topics
  37. PET Imaging2▲ 12×3 topics
  38. Phosphorylation2▲ 98×2 topics
  39. RNA methylation2▲ 34×1 topic
  40. m6A-seq2▲ 34×1 topic

Which research topics does Astex Pharmaceuticals publish most on?

By volume in 2022–2025: Acute Myeloid Leukemia Research, Ubiquitin and proteasome pathways, Histone Deacetylase Inhibitors Research and Protein Degradation and Inhibitors.

Acute Myeloid Leukemia R…1Acute Myeloid Leukemia Research: 1 fractional worksUbiquitin and proteasome…1Ubiquitin and proteasome pathways: 1 fractional worksHistone Deacetylase Inhi…1Histone Deacetylase Inhibitors Research: 1 fractional worksProtein Degradation and …1Protein Degradation and Inhibitors: 1 fractional worksT-cell and Retrovirus Studies: 1 fractional worksMelanoma and MAPK Pathways: 1 fractional worksComputational Drug Disco…1Computational Drug Discovery Methods: 1 fractional worksPneumocystis jirovecii pneumonia detection and treatment: 0 fractional worksChronic Myeloid Leukemia Treatments: 0 fractional worksEpigenetics and DNA Methylation: 0 fractional works
HematologyMolecular BiologyImmunologyComputational Theory and Mathematics1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Acute Myeloid Leukemia Research Hematology 1 works
  2. 2 Ubiquitin and proteasome pathways Molecular Biology 1 works
  3. 3 Histone Deacetylase Inhibitors Research Molecular Biology 1 works
  4. 4 Protein Degradation and Inhibitors Molecular Biology 1 works
  5. 5 T-cell and Retrovirus Studies Immunology 1 works
  6. 6 Melanoma and MAPK Pathways Molecular Biology 1 works
  7. 7 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
  8. 8 Pneumocystis jirovecii pneumonia detection and treatment Epidemiology 0 works
  9. 9 Chronic Myeloid Leukemia Treatments Hematology 0 works
  10. 10 Epigenetics and DNA Methylation Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.0%not open65.0%

World: 28% of research is openly available.

with international co-authors19.4%domestic only80.6%

World: 19% is written across borders.

How has Astex Pharmaceuticals's research output changed?

Output in 2018–2022 was 11% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.